Platelet-Function Testing in Patients Undergoing Neurovascular Procedures: Caught between a Rock and a Hard Place

被引：28
作者：
Comin, J. [2 ]
Kallmes, D. F. [1 ]
机构：
[1] Mayo Clin, Dept Radiol, Rochester, MN USA
[2] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia
来源：
AMERICAN JOURNAL OF NEURORADIOLOGY | 2013年 / 34卷 / 04期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; VASODILATOR-STIMULATED PHOSPHOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ELUTING STENT THROMBOSIS; OF-CARE ASSAY; FUNCTION PROFILES; ARTERY-DISEASE; CLOPIDOGREL NONRESPONDERS; RANDOMIZED-TRIAL;
D O I：
10.3174/ajnr.A3440
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In the context of neurointerventional procedures, clopidogrel hyper-responsiveness has been associated with hemorrhage; on the other hand, clopidogrel resistance has been associated with thromboembolism. This might seem to make a compelling argument in favor of routine platelet testing. Our reading of the literature leads us to conclude that routine platelet testing in neurointerventional procedures is not, unfortunately, ready for prime time.
引用
收藏
页码：730 / 734
页数：5
相关论文
共 49 条
  • [1] Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis - A case-control study
    Ajzenberg, N
    Aubry, P
    Huisse, MG
    Cachier, A
    El Amara, W
    Feldman, LJ
    Himbert, D
    Baruch, D
    Guillin, MC
    Steg, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) : 1753 - 1756
  • [2] Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention Results From the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) Randomized Study
    Aleil, Boris
    Jacquemin, Laurent
    De Poli, Fabien
    Zaehringer, Michel
    Collet, Jean-Philippe
    Montalescot, Gilles
    Cazenave, Jean-Pierre
    Dickele, Marie-Claude
    Monassier, Jean-Pierre
    Gachet, Christian
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (06) : 631 - 638
  • [3] Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramírez, C
    Sabaté, M
    Jimenez-Quevedo, P
    Hernández, R
    Moreno, R
    Escaned, J
    Alfonso, F
    Bañuelos, C
    Costa, MA
    Bass, TA
    Macaya, C
    [J]. DIABETES, 2005, 54 (08) : 2430 - 2435
  • [4] A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
    Angiolillo, Dominick J.
    Capranzano, Piera
    Goto, Shinya
    Aslam, Mohammed
    Desai, Bhaloo
    Charlton, Ronald K.
    Suzuki, Yoshie
    Box, Lyndon C.
    Shoemaker, Steven B.
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (18) : 2202 - 2211
  • [5] Functional effects of high Clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment
    Angiolillo, Dominick J.
    Costa, Marco A.
    Shoemaker, Steven B.
    Desai, Bhaloo
    Bernardo, Esther
    Suzuki, Yoshie
    Charlton, Ronald K.
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (04) : 440 - 445
  • [6] Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
    Angiolillo, Dominick J.
    Schneider, David J.
    Bhatt, Deepak L.
    French, William J.
    Price, Matthew J.
    Saucedo, Jorge F.
    Shaburishvili, Tamaz
    Huber, Kurt
    Prats, Jayne
    Liu, Tiepu
    Harrington, Robert A.
    Becker, Richard C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (01) : 44 - 55
  • [7] Aradi D, 2012, INT J CARDIOL
  • [8] Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity
    Aradi, Daniel
    Rideg, Orsolya
    Vorobcsuk, Andres
    Magyarlaki, Tamas
    Magyari, Balazs
    Konyi, Attila
    Pinter, Tuende
    Horvath, Ivan G.
    Komocsi, Andras
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (04) : 384 - 392
  • [9] The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial)
    Ari, Hasan
    Ozkan, Hakan
    Karacinar, Ali
    Ari, Selma
    Koca, Vedat
    Bozat, Tahsin
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 157 (03) : 374 - 380
  • [10] The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis
    Blindt, Ruediger
    Stellbrink, Katja
    de Taeye, Anita
    Mueller, Robert
    Kiefer, Paul
    Yagmur, Eray
    Weber, Christian
    Kelm, Malte
    Hoffmann, Rainer
    [J]. THROMBOSIS AND HAEMOSTASIS, 2007, 98 (06) : 1329 - 1334
12345